Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2011

01.04.2011 | Materno-fetal Medicine

Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora

verfasst von: Talita T. Rocchetti, Camila Marconi, Vera L. M. Rall, Vera T. M. Borges, José E. Corrente, Márcia G. da Silva

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine the prevalence of group B streptococci (GBS) in our population, and to assess the association between risk factors and vaginal flora with maternal rectovaginal colonization.

Method

Samples were obtained from 405 patients between 35 and 37 weeks of gestation. Swabs from the vaginal and perianal regions were cultured in Todd Hewitt and subcultured in blood agar. Colonies suggestive of GBS were submitted to catalase and CAMP test. The vaginal flora was evaluated on Gram stain vaginal smears. Socio-demographic and obstetric data were obtained by designed form. Considering maternal GBS colonization as the response variable, a logistic regression model was fitted by the stepwise method with quantitative and qualitative explanatory variables.

Results

The prevalence of GBS colonization was 25.4%. The most frequent vaginal flora abnormalities were cytolytic vaginosis (11.3%), followed by bacterial vaginosis (10.9%), candidosis (8.2%) and intermediate vaginal flora II (8.1%). Logistic regression analysis revealed that maternal age, number of sexual intercourse/week, occurrence of previous spontaneous abortion, presence of candidosis and cytolytic vaginosis were associated with streptococcal colonization.

Conclusion

The prevalence of GBS is high in pregnant women and is associated with sexual intercourse frequency, previous spontaneous abortion and the presence of candidosis or cytolytic vaginosis.
Literatur
1.
Zurück zum Zitat Schrag SJ, Zywicki S, Farley MM et al (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15–20PubMedCrossRef Schrag SJ, Zywicki S, Farley MM et al (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15–20PubMedCrossRef
2.
Zurück zum Zitat Schuchat A (1998) Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 11:497–513PubMed Schuchat A (1998) Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 11:497–513PubMed
4.
Zurück zum Zitat Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P (1994) Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 84:816–819PubMed Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P (1994) Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 84:816–819PubMed
5.
Zurück zum Zitat Tyrrel GL, Senzilet LD, Spika JS et al (2000) Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population based, active laboratory surveillance study-1996. J Infect Dis 182:168–173. doi:10.1086/315699 CrossRef Tyrrel GL, Senzilet LD, Spika JS et al (2000) Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population based, active laboratory surveillance study-1996. J Infect Dis 182:168–173. doi:10.​1086/​315699 CrossRef
6.
Zurück zum Zitat Boyer KM, Gotoff SP (1985) Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 35:267–280PubMed Boyer KM, Gotoff SP (1985) Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 35:267–280PubMed
7.
Zurück zum Zitat Schuchat A (1995) Epidemiology of group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother 49:19–25PubMedCrossRef Schuchat A (1995) Epidemiology of group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother 49:19–25PubMedCrossRef
8.
Zurück zum Zitat Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention (1996) MMWR Recomm Rep 45:1–24 Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention (1996) MMWR Recomm Rep 45:1–24
12.
Zurück zum Zitat Regan JA, Klebanoff MA, Nugent RP (1991) The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 77:604–610PubMed Regan JA, Klebanoff MA, Nugent RP (1991) The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 77:604–610PubMed
13.
Zurück zum Zitat Persson K, Bjerre B, Hansson H, Forsgren A (1981) Several factors influencing the colonization of group B streptococci—rectum probably the main reservoir. Scand J Infect Dis 13:171–175PubMed Persson K, Bjerre B, Hansson H, Forsgren A (1981) Several factors influencing the colonization of group B streptococci—rectum probably the main reservoir. Scand J Infect Dis 13:171–175PubMed
15.
Zurück zum Zitat Davies HD, Adair CE, Partlow ES, Sauve R, Low DE, McGeer A (1999) Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens: implications for GBS screening programs. Diagn Microbiol Infect Dis 35:169–176PubMedCrossRef Davies HD, Adair CE, Partlow ES, Sauve R, Low DE, McGeer A (1999) Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens: implications for GBS screening programs. Diagn Microbiol Infect Dis 35:169–176PubMedCrossRef
16.
Zurück zum Zitat Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G (2004) Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 190:1509–1519. doi:10.1016/j.ajog.2004.01.002 PubMedCrossRef Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G (2004) Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 190:1509–1519. doi:10.​1016/​j.​ajog.​2004.​01.​002 PubMedCrossRef
17.
Zurück zum Zitat Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA (1992) The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 79:369–373PubMedCrossRef Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA (1992) The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 79:369–373PubMedCrossRef
18.
Zurück zum Zitat Kubota T (1998) Relationship between maternal group B streptococcal colonization and regnancy outcome. Obstet Gynecol 92:926–930PubMedCrossRef Kubota T (1998) Relationship between maternal group B streptococcal colonization and regnancy outcome. Obstet Gynecol 92:926–930PubMedCrossRef
20.
Zurück zum Zitat Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301PubMed Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301PubMed
22.
Zurück zum Zitat Schrag S, Gorwitz PR, Fultz-Butts K, Schuchat A (2002) Prevention of perinatal group b streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 16:1–22 Schrag S, Gorwitz PR, Fultz-Butts K, Schuchat A (2002) Prevention of perinatal group b streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 16:1–22
23.
Zurück zum Zitat Moyo SR, Mudzori J, Tswana SA, Maeland JA (2000) Prevalence, capsular type distribution, anthropometric and obstetric factors of group B streptococcus (Streptococcus agalactiae) colonization in pregnancy. Cent Afr J Med 46:115–120PubMed Moyo SR, Mudzori J, Tswana SA, Maeland JA (2000) Prevalence, capsular type distribution, anthropometric and obstetric factors of group B streptococcus (Streptococcus agalactiae) colonization in pregnancy. Cent Afr J Med 46:115–120PubMed
25.
28.
Zurück zum Zitat Honig E, Mouton JW, Van der Meijden WI (2002) Epidemiology of vaginal colonisation with group B streptococci in a sexually transmitted disease clinic. Eur J Obstet Gynecol Reprod Biol 105:177–180. doi:10.1016/S0301-2115(02)00162-8 PubMed Honig E, Mouton JW, Van der Meijden WI (2002) Epidemiology of vaginal colonisation with group B streptococci in a sexually transmitted disease clinic. Eur J Obstet Gynecol Reprod Biol 105:177–180. doi:10.​1016/​S0301-2115(02)00162-8 PubMed
29.
Zurück zum Zitat Cibley LJ, Cibley LJ (1991) Cytolytic vaginosis. Am J Obstet Gynecol 165:1245–1249PubMed Cibley LJ, Cibley LJ (1991) Cytolytic vaginosis. Am J Obstet Gynecol 165:1245–1249PubMed
Metadaten
Titel
Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora
verfasst von
Talita T. Rocchetti
Camila Marconi
Vera L. M. Rall
Vera T. M. Borges
José E. Corrente
Márcia G. da Silva
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1439-8

Weitere Artikel der Ausgabe 4/2011

Archives of Gynecology and Obstetrics 4/2011 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.